← FDA Drug Approvals (Drugs@FDA)

SOLRIAMFETOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LIMITED · Approved 2024-12-11

Drug application

FDA Application #

ANDA218654

Application type

Abbreviated New Drug Application (Generic)

Brand name

SOLRIAMFETOL

Generic name

Solriamfetol

Active ingredients

SOLRIAMFETOL

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

HETERO LABS LIMITED

First approval

2024-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown